Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAST-AI: Cystectomy After Systemic Therapy With ADC and Immunotherapy

NCT06764095 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06764095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06764095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAST-AI: Cystectomy After Systemic Therapy With ADC and Immunotherapy
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Recruiting
Start date
January 8, 2025
Completion date
January 1, 2032
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced bladder urothelial carcinoma, locally advanced renal pelvis and ureter urothelial carcinoma, metastatic bladder urothelial carcinoma, metastatic renal pelvis and ureter urothelial carcinoma, stage iii bladder cancer ajcc v8, stage iv bladder cancer ajcc v8, stage iv renal pelvis and ureter cancer ajcc v8